SEATTLE, Sept. 4 /PRNewswire-FirstCall/ --
Dendreon Corporation (NASDAQ: DNDN) today announced that management will present at the following four upcoming investor conferences.
Rodman & Renshaw 11th Annual Health Care Conference
Wednesday, September 9, 2009
4:05 p.m. ET
Morgan Stanley 2009 Global Health Care Unplugged Conference
Tuesday, September 15, 2009
8:35 a.m. ET
BioCentury 16th Annual NewsMakers in the Biotech Industry Conference
Wednesday, September 16, 2009
1:30 p.m. ET
UBS 2009 Global Life Sciences Conference
Wednesday, September 23, 2009
1:00 p.m. ET
The presentations at Rodman & Renshaw, BioCentury NewsMakers and UBS will be audio webcast live and available for replay from Dendreon's website, http://www.dendreon.com/.
Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets TRPM8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com/.
DATASOURCE: Dendreon Corporation
CONTACT: Jennifer Williams, Investor Relations of Dendreon Corporation,
+1-206-829-1500
Web Site: http://www.dendreon.com/